What are the preferred single-agent taxane regimens for the treatment of recurrent or metastatic breast cancer?

Updated: Apr 23, 2020
  • Author: Joseph A Sparano, MD; Chief Editor: John V Kiluk, MD, FACS  more...
  • Print
Answer

Answer

Regimens are as follows:

  • Paclitaxel 175 mg/m 2 IV on day 1 every 3 wk or  80 mg/m 2 IV weekly or
  • Docetaxel 60-100 mg/m 2 IV on day 1 every 3 wk or  40 mg/m 2 IV weekly for 6 wk followed by a 2-wk rest and then repeated or
  • Albumin-bound paclitaxel 100 or 150 mg/m 2 IV on days 1, 8, and 15 every 4 wk or  260 mg/m 2 IV every 3 wk

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!